Clinical study on Xuanbai Qingfei Jiedu decoction combined with western medicine in the treatment of community acquired pneumonia(phlegm-heat obstructing lung syndrome)
Objective To study the effect of Xuanbai Qingfei Jiedu decoction combined with western medicine in the treatment of community acquired pneumonia(CAP)(phlegm-heat obstructing lung syndrome).Methods A total of 120 patients with CAP(phlegm-heat obstructing lung syndrom)admitted from February 2021 to February 2023 were selected as the research objects,and the patients were divided into western medicine group and combined group by random number table method,with 60 cases in each group.The western medicine group was treated with western medicine,and the combined group was treated with Xuanbai Qingfei Jiedu decoction on the basis of the western medicine group.The clinical efficacy,TCM syndrome scores,symptom disappearance time,defined daily dose(DDD)value,hospitalization time,hospitalization expenses,and serum inflammatory factors levels were compared between the two groups.Results The total effective rate of treatment in the combined group was 95.00%,which was significantly higher than 80.00%in the western medicine group(P<0.05).After treatment,the scores of fever,cough,phlegm obstruction,shortness of breath and palpitation in the combined group were lower than those in the western medicine group(P<0.05).The antipyretic time,cough/expectoration disappearance time,lung rale disappearance time and hospitalization time of the combined group were shorter than those of the western medicine group,the DDD value was lower than that of the western medicine group,and the hospitalization expenses was less than that of the western medicine group(P<0.05).After treatment,the levels of interleukin-6(IL-6),procalcitonin(PCT)and C-reactive protein(CRP)in the combined group were lower than those in the western medicine group(P<0.05).Conclusion The Xuanbai Qingfei Jiedu decoction combined with western medicine in the treatment of CAP(phlegm-heat obstructing lung syndrome)has ideal effect,which can reduce the degree of lung inflammation.
community acquired pneumoniaphlegm-heat obstructing lung syndromeXuanbai Qingfei Jiedu decoctioninflammatory factor
NETL
NSTL
万方数据
